Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Open Angle Glaucoma or Ocular Hypertension”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT06016972
What this trial is testing

Qlaris Phase 2 Study of QLS-111 in POAG And/or OHT Patients

Who this might be right for
Primary Open Angle Glaucoma (POAG)Primary Open Angle Glaucoma of Both EyesPrimary Open-Angle Glaucoma, Unspecified Eye+1 more
Qlaris Bio, Inc. 63
Large-scale testing (Phase 3)Study completedNCT01310777
What this trial is testing

Brinzolamide/Brimonidine Twice a Day (BID) Fixed Combination (FC) vs Brinzolamide BID and Brimonidine BID in Patients With Open Angle Glaucoma or Ocular Hypertension

Who this might be right for
Open-Angle GlaucomaOcular Hypertension
Alcon Research 771
Testing effectiveness (Phase 2)Study completedNCT01037036
What this trial is testing

The L-PPDS With Adjunctive Xalatan® Eye Drops in Subjects With OH or OAG

Who this might be right for
Ocular HypertensionOpen-Angle Glaucoma
Mati Therapeutics Inc. 15
Not applicableStudy completedNCT01999348
What this trial is testing

GANFORT® UD in Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT) in a Medical Setting

Who this might be right for
Glaucoma, Primary Open AngleOcular Hypertension
Allergan 1,553
Not applicableStudy completedNCT01632423
What this trial is testing

Lumigan® in Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT)

Who this might be right for
Glaucoma, Open-AngleOcular Hypertension
Allergan 10,337
Large-scale testing (Phase 3)Study completedNCT02981446
What this trial is testing

A Phase III Study Assessing the Safety and Efficacy of DE-117 Ophthalmic Solution Compared With Latanoprost Ophthalmic Solution in Subjects With OAG or OHT

Who this might be right for
Open Angle Glaucoma or Ocular Hypertension
Santen Pharmaceutical Co., Ltd. 370
Early research (Phase 1)Not Yet RecruitingNCT07641296
What this trial is testing

Evaluation of the Safety, Efficacy, Dose Response of the Bimatoprost Drug Ring System (BIM-DRS) in Pseudophakic Patients Diagnosed With Open Angle Glaucoma or Ocular Hypertension

Who this might be right for
GlaucomaOcular Hypertension
SpyGlass Pharma, Inc. 24
Post-approval studies (Phase 4)Study completedNCT00140062
What this trial is testing

Efficacy And Safety Of Xalatan Compared To Usual Care In Patients With Open Angle Glaucoma Or Ocular Hypertension.

Who this might be right for
Ocular HypertensionGlaucoma, Open-Angle
Pfizer 329
Not applicableActive Not RecruitingNCT07154810
What this trial is testing

Observational Study to Evaluate Long Term Outcomes for Ocular Hypertension and Glaucoma Patients Treated With the SpyGlass Bimatoprost Implant System / IOL Combination

Who this might be right for
GlaucomaCataractOcular Hypertension
SpyGlass Pharma, Inc. 23
Large-scale testing (Phase 3)Study completedNCT00051142
What this trial is testing

A Safety and Efficacy Study of Travoprost 0.004% Compared to Latanoprost 0.005% in Patients With Open-Angle Glaucoma (OAG) or Ocular Hypertension (OHT)

Who this might be right for
Glaucoma, Open-AngleOcular Hypertension
Alcon Research
Post-approval studies (Phase 4)Study completedNCT02338362
What this trial is testing

Inhaled Corticosteroids: Effect on Intraocular Pressure in Patients With Controlled Glaucoma

Who this might be right for
Ocular HypertensionGlaucoma, Open-Angle
University Health Network, Toronto 22
Not applicableNot Yet RecruitingNCT07589270
What this trial is testing

Direct Selective Laser Trabeculoplasty (DSLT) for Patients With Glaucoma or Ocular Hypertension Previously Treated With SLT

Who this might be right for
Ocular Hypertension GlaucomaPOAG
The New York Eye Surgery Center 60
Large-scale testing (Phase 3)Study completedNCT02250651
What this trial is testing

Efficacy and Safety of Bimatoprost Sustained-Release (SR) in Patients With Open-Angle Glaucoma or Ocular Hypertension

Who this might be right for
Glaucoma, Open-AngleOcular Hypertension
Allergan 528
Large-scale testing (Phase 3)Ended earlyNCT00767494
What this trial is testing

Travoprost/Brinzolamide Fixed Combination Versus Travatan and Versus AZOPT

Who this might be right for
GlaucomaOcular Hypertension
Alcon Research 17
Testing effectiveness (Phase 2)Study completedNCT00620256
What this trial is testing

Adjunctive Study of AL-37807 Ophthalmic Suspension

Who this might be right for
Open-Angle GlaucomaOcular Hypertension
Alcon Research 129
Early research (Phase 1)Ended earlyNCT01180062
What this trial is testing

Safety Study of Latanoprost Slow Release Insert

Who this might be right for
Primary Open Angle Glaucoma (POAG)Ocular Hypertension (OHT)
Daniel Moore 12
Post-approval studies (Phase 4)Study completedNCT01443988
What this trial is testing

Subjects With Open-angle Glaucoma, Pseudoexfoliative Glaucoma, or Ocular Hypertension Naïve to Medical and Surgical Therapy, Treated With Two Trabecular Micro-bypass Stents (iStent)or Travoprost

Who this might be right for
Open-angle Glaucoma
Glaukos Corporation 101
Post-approval studies (Phase 4)Study completedNCT01978600
What this trial is testing

Evaluation of Intraocular Pressure Using Simbrinza™ in Patients With Open-Angle Glaucoma or Ocular Hypertension

Who this might be right for
Open-Angle GlaucomaOcular Hypertension
Alcon Research 89
Testing effectiveness (Phase 2)Study completedNCT01062971
What this trial is testing

Clinical Study of A Fixed Combination of Timolol-Brimonidine-Dorzolamide

Who this might be right for
Primary Open Angle GlaucomaOcular Hypertension
Laboratorios Sophia S.A de C.V. 124
Early research (Phase 1)Study completedNCT03293992
What this trial is testing

The Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7058584 Following 7 Days of Instillation of Eye Drops in Patients With Primary Open Angle Glaucoma or Ocular Hypertension

Who this might be right for
Glaucoma, Open-angleOcular Hypertension
Hoffmann-La Roche 27
Next Page